JOE LAU, MD
Osteopathic Medicine at Madison Ave, New York, NY

License number

New York 237810

Personal information

See more information about JOE LAU at radaris.com

Name

Address

Phone

Joe Lau

5315 206Th St, Oakland Gdns, NY 11364

Joe Lau

5223 4Th Ave FL 2, Brooklyn, NY 11220

Joe Lau

5223 4Th Ave APT 2, Brooklyn, NY 11220

Joe Lau

315 E 93Rd St APT 4C, New York, NY 10128

Joe Lau

24018 67Th Ave, Little Neck, NY 11362

Professional information

See more information about JOE LAU at trustoria.com

Dr. Joe Lau, New Hyde Park NY - MD (Doctor of Medicine)

Specialties:

Cardiology

Address:

27005 76Th Ave SUITE 04000, New Hyde Park 11040
(718) 470-7330 (Phone), (718) 343-9762 (Fax)
1391 Madison Ave, New York 10029
(212) 241-4029 (Phone), (212) 876-1493 (Fax)

Procedures:

Ablation for Treatment of Cardiac Arrythmias, Cardiac Catheterization (incl. Coronary Angiography), Cardiac Imaging, Cardiac Myocardial Perfusion Imaging, Cardioversion, Elective, Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair, Chest CT (incl. Heart and Lungs), Coronary Angioplasty, Atherectomy and Stent, Peripheral Artery Catheterization, Tilt Testing or Cardiac Event Monitors

Conditions:

Aneurysm and Dissection of Heart, Angina and Acute Coronary Syndrome, Aortic Aneurysm, Aortic Ectasia, Aortic Valve Disease, Arrhythmias (incl. Atrial Fibrillation), Cardiomegaly, Cardiomyopathy, Carotid Artery Disease, Congestive Heart Failure, Coronary Artery Disease (CAD), Heart Attack (Acute Myocardial Infarction), Hyperlipidemia, Hypertension, Hypotension, Mitral Valve Disease, Pericardial Disease, Pulmonary Hypertension, Septal Defect, Syncope, Tricuspid Valve Disease

Certifications:

Cardiovascular Disease, 2010, Internal Medicine, 2008

Awards:

Healthgrades Honor Roll

Languages:

English

Education:

Medical School
Mount Sinai School of Medicine
Graduated: 2000
New York Presbyterian Hospital-New York Weill Cornell Center
Mount Sinai Hospital

Media At Bridgeport Hospital

Position:

media at Bridgeport Hospital

Location:

Greater New York City Area

Industry:

Broadcast Media

Work:

Bridgeport Hospital - media

Hybrid Fusion Protein Transcription Regulator To Induce Interferon Target Gene Expression

US Patent:

2005001, Jan 27, 2005

Filed:

Oct 3, 2002

Appl. No.:

10/492043

Inventors:

Curt Horvath - Wilmette IL, US
Joe Lau - New York NY, US

International Classification:

A61K038/21, C12P021/02, C12N015/86

US Classification:

424085400, 424192100, 530351000, 435069500, 435456000, 435325000

Abstract:

New hybrid or chimeric fusion polypeptide transcription regulators which induce interferon target gene expression are provided for use in anti-viral and anti-proliferative applications. The hybrid fusion proteins comprise the p48 interferon regulatory factor protein, or a functional portion thereof, fused to a transcriptional activation domain (TAD), or a functional portion thereof. More specifically, the p48 interferon regulatory factor protein is fused to a STAT transcriptional activation do main (TAD) (p48-STAT TAD). A particular p48-STAT TAD is p48-S2C, in which S2C is the TAD of STAT2. Another p48-TAD is p48-VP16 TAD, in which p48 is fused to the transcriptional activation domain of the VP16 protein of Herpes Simplex Virus (HSV). The p48-TAD nucleic acid sequences and encoded polypeptides can be employed for anti-viral treatment and for the treatment of cancers, tumors and neoplastic diseases.